CA-CEPTON-TECHNOLOGIES
Cepton, a leading provider of intelligent, lidar-based solutions, today announced a partnership with top perimeter security solutions provider, Barrier1 Systems. Using Cepton’s Helius™ Smart Lidar System , Barrier1 Systems is adding new layers of intelligence to its physical barrier systems to enable the next-generation of early-warning intrusion detection and onsite safety applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005303/en/
North Carolina-based Barrier1 Systems is working with global customers in the public and private sectors to install innovative new solutions that leverage the unique capabilities of Cepton ’s Helius system, which combines a network of Vista®-P lidar sensors with edge computing and advanced perception software, to deliver real-time, anonymized, 3D object detection, classification, tracking and velocity. The partnership demonstrates the versatility of Cepton’s lidar technology, and how smart lidar solutions are increasing security and safety in various types of public and private commercial spaces and facilities.
In one customer application, Barrier1 Systems has combined its barrier control systems with Helius to monitor the speed and direction of vehicles approaching entrance or exit points. If a vehicle exceeds a certain speed limit within a specified range, the system will flag it as a potential intrusion attempt and trigger an alert to the central system for further actions. By classifying vehicle travel direction, it can also guard against incoming threats through outbound roadways.
Deployments like the one above utilize the Cepton Vista lidar’s long range, high resolution imaging capabilities, and the Helius solution’s real-time, 3D information on object dimensions, locations and velocities. For example, Barrier 1 Systems uses Helius to detect and classify vehicles at 150 meters and keep track of their velocities to help diagnose whether there is a potential breach. The object information from Helius is much more accurate than from radars, thereby minimizing false positives and false negatives.
Barrier1 Systems has also deployed Cepton’s Helius system to help ensure facility security and onsite safety. For instance, a network of Vista-P90 lidar sensors has been installed at customer inventory sites to monitor access points. Helius generates useful information such as whether a detected object is a vehicle or a person, how fast it is moving and whether it is in a pre-defined exclusion zone. As lidars perform 24/7 under many weather and lighting conditions challenging for cameras, this helps facility managers continuously ensure property security and worker safety. Facilities can utilize the smart lidar data to flag potential accidents and breaches of access control.
Speaking of the partnership, Baxter Matthews, Vice President of Security Projects at Barrier1 Systems, said: “Cepton’s lidar technology and perception solution have allowed us to unleash a new set of innovations and capabilities when it comes to security and safety, which is critical given the range of threats and challenges faced today in both public and private spaces. The simplicity of installation of Cepton’s solution makes it easy for us to deploy and scale up quickly. Further, the anonymous nature of the lidar images, combined with their high accuracy, enables significant advancements in the state of the art for security and safety. A major customer liked the advantages of our solution so much that they want to do a nationwide implementation at all of their sites, which is incredible. What’s exciting is that we are just scratching the surface of what is possible because there are many untapped applications – in the perimeter security industry and beyond – where customers see tremendous potential for solutions arising from our partnership with Cepton.”
Dr. Jun Pei, Cepton’s co-founder and CEO, added: “Beyond its well-known role in the automotive industry, lidar is a versatile technology that enables a whole new level of safety and autonomy in many other applications. Our partnership with Barrier1 is a testament to this. We have designed our MMT®-based lidar solutions with customers’ perception needs in mind, and for security and safety solutions like the ones developed by Barrier1, we have focused on delivering a superior combination of accuracy, reliability and scalability. We look forward to continuing our work with Barrier1 to expand the use cases for lidar globally, by enabling enhanced safety and security solutions using lidar intelligence.”
About Cepton Technologies, Inc.
Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. Cepton’s patented MMT®-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan and India, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn .
About Barrier1
Barrier1 Systems, LLC (Barrier1 Systems) provides state-of-the-art robust physical barriers and security solutions using innovative products with unique capabilities that meet the customer’s site-specific needs and requirements. In the past 17 years, more than 4500 of our crash rated barrier systems have been fielded in 13 countries.
Barrier1 Systems employs expertise in engineering, welding and metal works, controls & alarms, electronics, power systems, programming, manufacturing, and installation. The company was founded in 2002. Barrier1 Systems does engineering and direct manufacturing for its products and provides post-installation support. For more information about Barrier1 visit www.barrier1.us .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005303/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
